Fairvalue-Calculator Fairvalue-Calculator
EN DE

Zoono Group (ZOONF) Fair Value & Analysis

Consumer Defensive · US · Market cap $18.2M

Price$0.0445
Fair Value$0.0825
Upside+85.5%
Quality95/100
Evidence: Low Range $0.0558 – $0.1092

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Zoono Group (ZOONF) currently trades at $0.0445, while our model-based Fair Value estimate is $0.0825 — implying the stock looks roughly 85.5% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Zoono Group Limited, together with its subsidiaries, engages in the research, development, and sale of a range of antimicrobial products in New Zealand, Australasia, Asia, the United States, India, the United Kingdom, and Europe. It offers hand and surface sanitisers, textile applicator, and mould remediation products. Zoono Group Limited was founded in 2007 and is headquartered in Auckland, New Zealand.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Zoono Group (ZOONF) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0825 versus a price of $0.0445 — about +86% (undervalued). Model-based estimate, not financial advice.
What is the fair value of ZOONF?
Our 21-model fair value for Zoono Group is $0.0825 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0445.
What is the quality score of ZOONF?
Zoono Group has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.